Open-label feasibility study demonstrates treatment acceptability and reduced minority stress in transgender emerging adults, suggesting viability for full-scale clinical trials.
• Transcending pilot findings demonstrate that it is possible to directly target proximal minority stressors and that these are malleable to change among transgender and gender diverse (TGD) individuals. • The present results show support for both treatment acceptability from participant perspectives, as well as proof-of-concept for the intervention. • Participants endorsed: (1) feeling less alone and being more connected to other TGD individuals; (2) increased ability to cope with and challenge minority stress cognitions through increased cognitive flexibility; (3) increased sense of hope about the future; and (4) an increased sense of confidence in themselves. • These preliminary findings provide the necessary data and support for a larger scale clinical trial for this vulnerable population, where improved and targeted interventions are critically warranted.
No takes yet. Share an insight, caveat, or question.
Hatchard et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: